Ocubio is a company that produces eye drops for the treatment of ocular surface conditions. Its products include autologous serum eye drops made from patient blood serum and an allogeneic human platelet lysate eye drop, OB-1, which is in clinical development for dry eye disease. The company supplies these products to ophthalmologists, optometrists, and other licensed eye care providers who treat dry eye disease and related ocular surface conditions.